A tiered decisional framework for genetic epileptic syndromes with or without encephalopathies: from standard care to investigational strategies
Expert Review of Clinical Pharmacology · 2026
DOI: 10.1080/17512433.2026.2652967 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, 2026. Verfasst von Lorenzo Perilli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pediatrics, Department of Molecular Medicine and Development, Azienda Ospedaliero-Universitaria Senese, University of Siena, Siena, Italy. Hauptthemen laut MEDLINE: Epilepsy, Epileptic Syndromes, Brain Diseases, Neurodevelopmental Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 211 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Developmental and epileptic encephalopathies (DEEs), epilepsy-associated neurodevelopmental disorders (NDD), and epileptic syndromes with or without encephalopathy (ES±E) share overlapping genetic architectures where both etiology and seizures impair development. Despite genomic advances, many patients remain pharmacoresistant, and molecular diagnoses seldom translate into targeted treatments. This review connects mechanistic categories to precision therapies, providing a clinical decision-making framework. AREA COVERED: We outline pharmacological and investigational strategies-including antiseizure medications, dietary therapies, and disease-modifying approaches-across major mechanistic categories, including ion channel/receptor dysfunctions, synaptic/signaling defects, metabolic disorders, and neurodegenerative storage diseases. For each condition, potential therapeutic options are interpreted within a hierarchical precision-based framework, ranging from empiric seizure-type-driven treatments to gene-specific molecular interventions. A narrative literature search was conducted across major databases for English-language articles on DEEs, NDD, ES±E, and precision therapeutic approaches published up to early 2026. We categorized potential therapeutic interventions into five hierarchical tiers based on etiological specificity and evidence. Classification, achieved by expert consensus, distinguishes established (Tiers 1-3) from emerging strategies (Tiers 4-5). EXPERT OPINION: Progress depends on early etiological diagnosis and timely, mechanism-informed therapy. Future advances require expanded genomic testing, natural history studies, mechanism-based biomarkers, and innovative trial designs tailored to complex pediatric populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pediatrics, Department of Molecular Medicine and Development, Azienda Ospedaliero-Universitaria Senese, University of Siena, Siena, Italy.
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
- Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
- Pediatrics Unit, Neuroscience, Mental Health and Sense Organs (NESMOS) Department, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
- Department of Pediatrics, University of Perugia, Perugia, Italy.
- IRCCS 'Giannina Gaslini', Full Member of ERN-Epicare, Genoa, Italy.
Zitieren
APA
Perilli, L., Ferretti, A., Riva, A., Grosso, S., Verrotti, A., & Striano, P. (2026). A tiered decisional framework for genetic epileptic syndromes with or without encephalopathies: from standard care to investigational strategies. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2026.2652967
Vancouver
Perilli L, Ferretti A, Riva A, Grosso S, Verrotti A, Striano P. A tiered decisional framework for genetic epileptic syndromes with or without encephalopathies: from standard care to investigational strategies. Expert Review of Clinical Pharmacology. 2026. doi:10.1080/17512433.2026.2652967
BibTeX
@article{Perilli2026,
author = {Perilli, Lorenzo and Ferretti, Alessandro and Riva, Antonella and Grosso, Salvatore and Verrotti, Alberto and Striano, Pasquale},
title = {A tiered decisional framework for genetic epileptic syndromes with or without encephalopathies: from standard care to investigational strategies},
journal = {Expert Review of Clinical Pharmacology},
year = {2026},
doi = {10.1080/17512433.2026.2652967}
}
EUVIMED